Manentia
AI in Healthcare| B2B,B2G | Seed
Bangalore, India
Manentia AI is a deeptech healthtech startup transforming radiology with a regulatory-ready AI platform that integrates seamlessly with PACS/RIS to deliver real-time detection, triage, and reporting for lung and brain scans.
With 75+ hospitals, 12 government partnerships, and 4 patents (2 granted), Manentia leads the space in AI-driven diagnostics — achieving >95% accuracy, >96% sensitivity, and up to 40% faster turnaround, tackling the global radiologist shortage at scale.
Founders
Anuj Chandalia
CEO | Founder
Btech (Computer Science)
4+ years experience in AI/ML product leadership, diagnostic imaging
Ex‑Google (Machine Learning Engineer) | Ex‑Le Grand India (Software Engineer) | Ex‑Ematron Pvt. Ltd. (Software Engineer)
Jitender Singh Virk
CTO | CO- Founder
Btech (Computer Science)
ME-CSE (with AI &ML Specialization)
7+ years experience in AI/ML engineering
Ex‑PGIMER (Diffusion MRI Processor) | Ex‑IIT Ropar (Research Assistant) | Ex‑IBM CE Headstar (Big Data Intern)
Key Highlights
Revenue (FY'25)
INR 1.9 Cr
Confirmed PO's
INR 8 Cr
(Lal Path labs,TATA,C15)
Projected Revenue (FY'26)
INR 12 Cr
Detection Accuracy
95%
Gross Margins
68-72%
Hospitals Onboarded
75+ (12 Govt)
Key Clientele
Deal Details
Current Deal Round
Seed
Round Size
INR 15 Cr (3 Cr committed)
Instrument
Convertible note
Soonicorn Platform Fee
Admin Fee: 2% of investment amount
Carry: 10%
Valuation
Cap: INR 45 Cr (Discount terms:
Within 6 months- NA
Post 6 months- 20% Discount)
Minimum Ticket Size per Investor
INR 3,00,000
*AIF Condition : Consolidated commitment for AIF should be more than INR 25 Lacs to qualify as a valid entry to the cap table
Deal Runners
Smridh Kohli
Smridh@soonicornventures.com
+91 9205431769
Documents
Pitch Call Recording
Media
Discover the Future of AI in Healthcare: 2025 & Beyond
The future of AI in healthcare industry is proving to be promising as artificial intelligence (AI) improves patient care and operational efficiency. For instance, advanced diagnostics algorithms detect diseases with accuracy, while AI-assisted robotic surgeries improve precision and reduce recovery times. In drug discovery, AI accelerates the identification of potential treatments and shortens the development cycle.
